Advanced search
1 file | 2.11 MB Add to list

Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age

(2010) BONE. 46(4). p.1038-1042
Author
Organization
Keywords
BONE-MINERAL DENSITY, RANDOMIZED CLINICAL-TRIAL, LONG-TERM COMPLICATION, POSTMENOPAUSAL OSTEOPOROSIS, BISPHOSPHONATE TREATMENT, HIP FRACTURE, ALENDRONATE THERAPY, ANTIRESORPTIVE AGENTS, COST-EFFECTIVENESS, Clinical trial, ZOLEDRONIC ACID, Strontium Ranelate, Elderly population, Antiosteoporotic treatment, Osteoporosis, Osteoporotic fracture

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 2.11 MB

Citation

Please use this url to cite or link to this publication:

MLA
Seeman, Ego, et al. “Five Years Treatment with Strontium Ranelate Reduces Vertebral and Nonvertebral Fractures and Increases the Number and Quality of Remaining Life-Years in Women over 80 Years of Age.” BONE, vol. 46, no. 4, 2010, pp. 1038–42, doi:10.1016/j.bone.2009.12.006.
APA
Seeman, E., Boonen, S., Borgstrom, F., Vellas, B., Aquino, J.-P., Semler, J., … Reginster, J.-Y. (2010). Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. BONE, 46(4), 1038–1042. https://doi.org/10.1016/j.bone.2009.12.006
Chicago author-date
Seeman, Ego, Steven Boonen, Frederik Borgstrom, Bruno Vellas, Jean-Pierre Aquino, Jutta Semler, Claude-Laurent Benhamou, Jean Kaufman, and Jean-Yves Reginster. 2010. “Five Years Treatment with Strontium Ranelate Reduces Vertebral and Nonvertebral Fractures and Increases the Number and Quality of Remaining Life-Years in Women over 80 Years of Age.” BONE 46 (4): 1038–42. https://doi.org/10.1016/j.bone.2009.12.006.
Chicago author-date (all authors)
Seeman, Ego, Steven Boonen, Frederik Borgstrom, Bruno Vellas, Jean-Pierre Aquino, Jutta Semler, Claude-Laurent Benhamou, Jean Kaufman, and Jean-Yves Reginster. 2010. “Five Years Treatment with Strontium Ranelate Reduces Vertebral and Nonvertebral Fractures and Increases the Number and Quality of Remaining Life-Years in Women over 80 Years of Age.” BONE 46 (4): 1038–1042. doi:10.1016/j.bone.2009.12.006.
Vancouver
1.
Seeman E, Boonen S, Borgstrom F, Vellas B, Aquino J-P, Semler J, et al. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. BONE. 2010;46(4):1038–42.
IEEE
[1]
E. Seeman et al., “Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age,” BONE, vol. 46, no. 4, pp. 1038–1042, 2010.
@article{1194250,
  author       = {{Seeman, Ego and Boonen, Steven and Borgstrom, Frederik and Vellas, Bruno and Aquino, Jean-Pierre and Semler, Jutta and Benhamou, Claude-Laurent and Kaufman, Jean and Reginster, Jean-Yves}},
  issn         = {{8756-3282}},
  journal      = {{BONE}},
  keywords     = {{BONE-MINERAL DENSITY,RANDOMIZED CLINICAL-TRIAL,LONG-TERM COMPLICATION,POSTMENOPAUSAL OSTEOPOROSIS,BISPHOSPHONATE TREATMENT,HIP FRACTURE,ALENDRONATE THERAPY,ANTIRESORPTIVE AGENTS,COST-EFFECTIVENESS,Clinical trial,ZOLEDRONIC ACID,Strontium Ranelate,Elderly population,Antiosteoporotic treatment,Osteoporosis,Osteoporotic fracture}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{1038--1042}},
  title        = {{Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age}},
  url          = {{http://dx.doi.org/10.1016/j.bone.2009.12.006}},
  volume       = {{46}},
  year         = {{2010}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: